Basics Bio-Techne Corp Bio-Techne Corp and is a biotechnology company which develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products. IPO Date: March 1, 1989 Sector: Healthcare Industry: Life Sciences Tools and Services Market Cap: $9.74B Activated in VL: True Average Daily Range Avg Daily Range: $1.48 | 1.15% Avg Daily Range (30 D): $1.09 | 1.96% Avg Daily Range (90 D): $0.97 | 1.80% Institutional Daily Volume Avg Daily Volume: .28M Avg Daily Volume (30 D): 2.15M Avg Daily Volume (90 D): 1.9M Trade Size Avg Trade Size (Sh.): 62 Avg Trade Size (Sh.) (30 D): 55 Avg Trade Size (Sh.) (90 D): 56 Institutional Trades Total Inst.Trades: 7,327 Avg Inst. Trade: $4.83M Avg Inst. Trade (30 D): $3.71M Avg Inst. Trade (90 D): $3.72M Avg Inst. Trade Volume: .3M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $8.58M Avg Closing Trade (30 D): $17.97M Avg Closing Trade (90 D): $16.04M Avg Closing Volume: 404.13K     News Sep 15, 2025 @ 9:29 PM Mdxhealth Announces Closing of Exosome Diagnostics... Source: Globe Newswire Sep 3, 2025 @ 6:45 PM Bio-Techne Stock Upgraded As Analyst Flags Attract... Source: Vandana Singh Aug 14, 2025 @ 2:00 PM Recombinant Human Hair Keratin Protein Market 2025... Source: Towards Healthcare Aug 6, 2025 @ 10:08 PM Bio-Techne (TECH) Q4 EPS Rises 8.2% Source: Jesterai Aug 6, 2025 @ 10:30 AM BIO-TECHNE DECLARES DIVIDEND Source: Prnewswire Financials   TTM Q4 2025 FY 2025 Basic EPS $.47 $-.11 $.47 Diluted EPS $.46 $-.11 $.46 Revenue $ 1.22B $ 316.96M $ 1.22B Gross Profit $ 790.27M $ 198.81M $ 790.27M Net Income / Loss $ 73.4M $ -17.68M $ 73.4M Operating Income / Loss $ 102.26M $ -23.86M $ 102.26M Cost of Revenue $ 429.36M $ 118.15M $ 429.36M Net Cash Flow $ -1.53M $ 8.16M $ -1.53M PE Ratio 138.67     Splits Nov 30, 2022:   4:1 Nov 10, 2022:   4:1 Dec 04, 2000:   2:1